The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 6, 2012, Pages 956-964

  Hermanides, Renicus S ^a   Van Werkum, J Wouter ^b   Ottervanger, Jan Paul ^a   Breet, Nicoline J ^b   Gosselink, A T Marcel ^a   Van Houwelingen, K Gert ^c   Dambrink, Jan Henk E ^a   Hamm, Christian ^d   Ten Berg, Jurrien M ^b   Van't Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d KERCKHOFF HEART CENTER   (Germany)

Author keywords

corrected TIMI frame count; glycoprotein IIb IIIa inhibitors; high bolus dose tirofiban; primary percutaneous coronary intervention; ST segment elevation myocardial infarction; thrombus burden

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PLACEBO; TIROFIBAN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE AGGREGATION; THROMBUS; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY THROMBOSIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME; TYROSINE; VASCULAR PATENCY;

EID: 84860626649     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23165     Document Type: Article

References (26)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK,. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004; 110: 588-636.
2. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, Mattos L, Lansky AJ, O'Neill WW, Grines CL,. Normal flow (TIMI 3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction. Circulation 2001; 104: 636-641.
3. White CJ, Ramee SR, Collins TJ, Escobar AE, Karsan A, Shaw D, Jain SP, Bass TA, Heuser RR, Teirstein PS, Bonan R, Walter PD, Smalling RW,. Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation 1996; 93: 253-258.
4. Singh M, Berger PB, Ting HH, Rihal CS, Wilson SH, Lennon RJ, Reeder GS, Bresnahan JF, Holmes DR Jr,. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). Am J Cardiol 2001; 88: 1091-1096.
5. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr,. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 58: 210-247.
6. van 't Hof AWJ, ten Berg JM, Heestermans AA, Dill T, Funck RC, van Werkum JW, Dambrink JH, Suryapranata H, van Houwelingen KG, Ottervanger JP, Stella PR, Giannitsis E, Hamm C,; Ongoing Tirofiban In Myocardial Infarction Evaluation (On-TIME) 2 study group. Pre-hospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): A multicentre, double-blind, randomised controlled trial. Lancet 2008; 372: 537-546.
7. ten Berg JM, van 't Hof AWJ, Dill T, Heestermans AA, van Werkum JW, Mosterd A, van Houwelingen KG, Koopmans PC, Stella PR, Boersma E, Hamm C,; On behalf of the Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Effect of early, pre-hospital initiation of high-bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short and long-term clinical outcome. J Am Coll Cardiol 2010; 55: 2446-2455.
8. Boersma E, Maas AC, Deckers JW, Simoons ML,. Early thrombolytic therapy in acute myocardial infarction: Reappraisal of the golden hour. Lancet 1996; 348: 771-775.
9. van 't Hof AWJ, Hamm C, Rasoul S, Guphta S, Paolini JF, ten Berg JM,; on behalf of the On-TIME 2 investigators. Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: Rationale and study design. EuroInterv 2007; 3: 371-380.
10. Principal investigators of CASS and Associates. National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. Circulation 1981; 63 (Suppl I): I-1-I-139.
11. TIMI study group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312: 932-936.
12. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E,. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: A TIMI 14 substudy. Circulation 2001; 103: 2550-2554.
13. van 't Hof AWJ, Liem A, Suryapranata H, Hoorntje JCA, de Boer MJ, Zijlstra F,. Angiographic assessment of myocardial infarction in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998; 97: 2302-2306.
14. Gibson CM, Cannon CP, Daley Wl, Dodge JT Jr., Alexander B Jr., Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E,. The TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888.
15. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AWJ, Hoorntje JCA, Suryapranata H,. Incidence and clinical significance of distal embolisation during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23: 1112-1117.
16. Assmann SF, Pocock SJ, Enos LE, Kasten LE,. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355: 1064-1069.
17. Prati F, Petronio S, van Boven AJ, Tendera M, de Luca L, de Belder MA, Galassi AR, Imola F, Montalescot G, Peruga JZ, Barnathan ES, Ellis S, Savonitto S., Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: The FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study. JACC Cardiovasc Interv 2010; 3: 1284-1291.
18. Henriques JP, Zijlstra F, van 't Hof AWJ, de Boer MJ, Dambrink JHE, Gosselink ATM, Hoorntje JCA, Suryapranata H,. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003; 107: 2115-2119.
19. Constantini C, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, Stuckey T, Turco M, Gersh BJ, Tcheng JE, Garcia E, Griffin JJ, Guagliumi G, Leon MB, Lansky AJ,. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol 2004; 44: 305-312.
20. Tan WA, Moliterno DJ,. TIMI flow and surrogate end points: What you see is not always what you get. Am Heart J 1998; 36: 570-573.
21. Collet JP, Montalescot G, Lestly C, Mishal Z, Soria J, Choussat R, Drobinski G, Soria C, Pinton P, Barragan P, Thomas D,. Effects of abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation 2001; 103: 2328-2331.
22. Fokkema ML, Vlaar PJ, Svilaas T, Vogelzang M, Amo D, Diercks GF, Suurmeijer AJ, Zijlstra F,. Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J 2009; 30: 908-915.
23. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, Lampros KM, Serruys PW,. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2007; 50: 573-873.
24. Heestermans AA, van Werkum JW, Hamm C, Dill T, Gosselink ATM, de Boer MJ, van Houwelingen KG, Hoorntje JCA, Koopmans PC, ten Berg JM, van't Hof AWJ,. Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose tirofiban in ST-segment elevation myocardial infarction. J Thromb Haemost 2009; 10: 1612-1618.
25. Zhao XQ, Theroux P, Snapinn SM, Sax FL,. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: Angiographic results from the PRISM-PLUS trial (platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms. Circulation 1999; 100: 1609-1615.
26. van den Brand M, Laarman GJ, Steg PG, de Scheerder I, Heyndrickx G, Beatt K, Kootstra J, Simoons ML,. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Eur Heart J 1999; 20: 1572-1578.